Cannabinoid receptor type 1 immunoreactivity and disease severity in human epithelial ovarian tumors

American Journal of Obstetrics and Gynecology

Volumn 211, Issue 3, 2014, Pages 234.e1-234.e6

  Messalli, Enrico Michelino ^a   Grauso, Flavio ^a   Luise, Rossella ^a   Angelini, Anna ^b   Rossiello, Raffaele ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Pathologic Service POS Maria Del Popolo Degli Incurabili   (Italy)

Author keywords

CB1 receptor; endocannabinoids; fatty acid amide hydrolase; ovarian tumors

Indexed keywords

CANNABINOID 1 RECEPTOR; FATTY ACID AMIDASE;

ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; OVARY CANCER; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CB1-RECEPTOR; ENDOCANNABINOIDS; FATTY ACID AMIDE HYDROLASE; OVARIAN TUMORS;

AMIDOHYDROLASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; RECEPTOR, CANNABINOID, CB1;

EID: 85058721576     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2014.04.004     Document Type: Article

References (32)

1. D.J. Hermanson, and L.J. Marnett Cannabinoids, endocannabinoids, and cancer Cancer Metastasis Rev 30 2011 599 612
2. R.G. Pertwee Emerging strategies for exploiting cannabinoid receptor agonists as medicines Br J Pharmacol 156 2009 397 411
3. K. Starowicz, S. Nigam, and V. Di Marzo Biochemistry and pharmacology of endovanilloids Pharmacol Ther 114 2007 13 33
4. A.J. Brown Novel cannabinoid receptors Br J Pharmacol 152 2007 567 575
5. A.H. Taylor, C. Ang, S.C. Bell, and J.C. Konie The role of the endocannabinoid system in gametogenesis, implantation and early pregnancy Hum Reprod Update 13 2007 501 513
6. S. Galiegue, S. Mary, and J. Marchand et al. Expression of central and peripheral cannabinoid receptors in human immune tissue and leukocyte subpopulations Eur J Biochem 232 1995 54 61
7. S.P. Kenney, R. Kekuda, and P.D. Prasad et al. Cannabinoid receptors and their role in the regulation of the serotonin transporter in the human placenta Am J Obstet Gynecol 181 1999 491 497
8. D. Parolaro, P. Massi, T. Rubino, and E. Monti Endocannabinoids in the immune system and cancer Prostagland Leukotr Essent Fatty Acids 66 2002 319 332
9. O.M. Habayed, A.H. Taylor, S.C. Bell, D.J. Taylor, and J.C. Konje Expression of the endocannabinoid system in human placenta and its role in trophoblast proliferation Endocrinology 9 2008 5052 5060
10. H.H. Schmid Pathways and mechanism of N-acylethanolamine biosynthesis: can anandamide be generated selectively? Chem Physics Lipids 108 2000 71 78
11. R.I. Wilson, and R.A. Nicoll Endocannabinoid signaling in the brain Science 296 2002 678 682
12. T. Bisogno, N. Sepe, D. Melck, S. Maurelli, L. De Petrocellis, and V. Di Marzo Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells Biochem J 322 1997 671 677
13. D.K. Giang, and B.F. Cravatt Molecular characterization of human and mouse fatty acid amide hydrolases Proc Natl Acad Sci USA 94 1997 2238 2242
14. M. Bifulco, C. Laezza, S. Pisanti, and P. Gazzerro Cannabinoids and cancer: pros and cons of an antitumor strategy Br J Pharmacol 148 2006 123 135
15. N. Freimuth, R. Ramer, and B. Hinz Antitumorigenic effects of cannabinoids beyond apoptosis J Pharmacol Exp Ther 332 2010 336 344
16. M.R. El Talantini, A.H. Taylor, and J.C. Elson et al. Localisation and function of the endocannabinoid system in the humane ovary PLos One 4 2009 4579
17. P. Bagavandoss, and S. Grimshaw Temporal and spatial distribution of the cannabinoid receptors (CB1, CB2) and fatty acid amide hydroxylase in the rat ovary Anat Rec (Hoboken) 293 2010 1425 1432
18. M.M. Caffarel, C. Andradas, and E. Mira et al. Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition Mol Cancer 9 2010 196 206
19. J. Guindon, and A.G. Hohmann The endocannabinoid system and cancer: therapeutic implication Br J Pharmacol 163 2011 1447 1463
20. L. De Petrocellis, D. Melck, and A. Palmisano et al. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation Proc Natl Acad Sci USA 95 1998 8357 8380
21. D. Melck, D. Rueda, I. Galve-Roperh, L. De Petrocellis, M. Guzmán, and V. Di Marzo Involvement of the cAMP/ protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells FEBS Lett 463 1999 235 240
22. D. Melck, L. De Petrocellis, and P. Orlando et al. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation Endocrinology 141 2000 118 126
23. M. Bifulco, C. Laezza, M. Valenti, A. Ligresti, G. Portella, and V. Di Marzo A new strategy to block tumor growth by inhibiting endocannabinoid inactivation FASEB J 18 2004 1606 1608
24. S. Oesch, and J. Gertsch Cannabinoid receptor ligands as potential anticancer agents - high hopes for new therapies? J Pharm Pharmacol 61 2009 839 853
25. S.C. Chung, P. Hammarsten, and A. Josefsson et al. A high cannabinoid receptors CB1 immunoreactivity is associated with disease severity and outcome in prostate cancer Eur J Cancer 45 2009 174 182
26. C.W. Michalski, F.E. Oti, and M. Erkan et al. Cannabinoids in pancreatic cancer: correlation with survival and pain Int J Cancer 122 2008 742 750
27. S.B. Gustafsson, R. Palmqvist, and M.L. Henriksson et al. High tumour cannabinoid Cb1 receptor immunoreactivity negatively impacts disease-specific survival in stage II microsatellite stable colorectal cancer PLoS One 6 2011 23003
28. A. Ligresti, T. Bisogno, and I. Matias et al. Possible endocannabinoid control of colorectal cancer growth Gastroenterology 125 2003 677 687
29. X. Xu, Y. Liu, and S. Huang et al. Overexespression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma Cancer Genet Cytogenet 171 2006 31 38
30. V. Di Marzo, M. Bifulco, and L. De Petrocellis The endocannabinoid system and its therapeutic exploitation Nat Rev Drug Discov 3 2004 771 784
31. V. Di Marzo, and S. Petrosino Endocannabinoids and the regulation of their levels in health and disease Curr Opin Lipidol 18 2007 129 140
32. V. Di Marzo Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov 7 2008 438 455